Therapeutic pathology
51 – 60 of 152
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy : A Population-Based Cohort Study
Tryggvadottir, Helga LU ; Sandén, Emma LU ; Björner, Sofie LU ; Bressan, Alessandra ; Ygland Rödström, Maria ; Khazaei, Somayeh LU ; Edwards, Dean P. ; Nodin, Björn LU ; Jirström, Karin LU
and Isaksson, Karolin
LU
, et al.
(2021)
In Frontiers in Oncology
11.
- Contribution to journal › Article
-
Mark
Development of a novel weighted ranking method for immunohistochemical quantification of a heterogeneously expressed protein in gastro-esophageal cancers
Richards, Cathy E. ; Sheehan, Katherine M. ; Kay, Elaine W. ; Hedner, Charlotta LU ; Borg, David LU ; Fay, Joanna ; O’grady, Anthony ; Hill, Arnold D.K. ; Jirström, Karin LU
and Hopkins, Ann M.
(2021)
In Cancers
13(6).
- Contribution to journal › Article
-
Mark
The prognostic impact of the tumour stroma fraction : A machine learning-based analysis in 16 human solid tumour types
Micke, Patrick ; Strell, Carina ; Mattsson, Johanna ; Martín-Bernabé, Alfonso ; Brunnström, Hans LU
; Huvila, Jutta
; Sund, Malin
; Wärnberg, Fredrik
; Ponten, Fredrik
and Glimelius, Bengt
, et al.
(2021)
In EBioMedicine
65.
- Contribution to journal › Article
-
Mark
Human epidermal growth factor receptor-3 expression is regulated at transcriptional level in breast cancer settings by junctional adhesion molecule-a via a pathway involving beta-catenin and foxa1
Cruz, Rodrigo G.B. ; Madden, Stephen F. ; Richards, Cathy E. ; Vellanki, Sri Harikrishna ; Jahns, Hanne ; Hudson, Lance ; Fay, Joanna ; O’farrell, Naoimh ; Sheehan, Katherine and Jirström, Karin LU
, et al.
(2021)
In Cancers
13(4).
- Contribution to journal › Article
-
Mark
Randomized Phase II trial of combination chemotherapy with panitumumab or bevacizumab for patients with inoperable biliary tract cancer without KRAS exon 2 mutations
- Contribution to journal › Article
-
Mark
Development and validation of a lifestyle-based model for colorectal cancer risk prediction : the LiFeCRC score
- Contribution to journal › Article
-
Mark
Pre- and Postoperative Circulating IGF-I, IGFBP-3, and IGFBP-7 Levels in Relation to Endocrine Treatment and Breast Cancer Recurrence : A Nested Case-Control Study
Rosendahl, Ann H. LU ; Björner, Sofie LU ; Ygland Rödström, Maria ; Jirström, Karin LU
; Borgquist, Signe
LU
; Ingvar, Christian
LU
; Pollak, Michael N.
and Jernström, Helena
LU
(2021)
In Frontiers in Oncology
11.
- Contribution to journal › Article
-
Mark
Prognostic impact of tumor-specific insulin-like growth factor binding protein 7 (IGFBP7) levels in breast cancer : A prospective cohort study
Godina, Christopher LU
; Khazaei, Somayeh
LU
; Tryggvadottir, Helga
LU
; Visse, Edward
LU
; Nodin, Björn
LU
; Jirström, Karin
LU
; Borgquist, Signe
LU
; Bosch, Ana
LU
; Isaksson, Karolin
LU
and Jernström, Helena
LU
(2021)
In Carcinogenesis
42(11).
p.1314-1325
- Contribution to journal › Article
-
Mark
The tumor immune microenvironment and clinical outcome in patients with esophageal and gastric adenocarcinoma
(2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Metabolic factors and the risk of small intestine cancers : Pooled study of 800 000 individuals in the metabolic syndrome and cancer project
Nagel, Gabriele ; Bjørge, Tone ; Jaensch, Andrea ; Peter, Raphael S. ; Häggström, Christel ; Lang, Alois ; Engeland, Anders ; Teleka, Stanley LU ; Jirström, Karin LU
and Lindquist, David
, et al.
(2021)
In International Journal of Cancer
149(1).
p.66-74
- Contribution to journal › Article